Skip to main content
Premium Trial:

Request an Annual Quote

New Products: IntelliCyt's iQue Screener

Premium

IntelliCyt recently announced the commercial launch of its iQue Screener.

According to the Albuquerque, NM-based company, the iQue is a high-throughput, high-content, integrated analyzer designed for screening cells and beads in suspension.

Using the system, researchers can obtain information on a cell-by-cell basis in 96- and 384-well microplates, IntelliCyt said. The system is capable of processing application-specific MultiCyt reagent kits, and the resulting data can be analyzed using IntelliCyt's ForeCyt software.

IntelliCyt also announced that it has obtained a CE Mark for the system in Europe.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.